Clinical trials: Ocular Hypertension, pill or tablet or capsule or oral, open to volunteers
- Condition Ocular Hypertension
- Drug or intervention pill OR tablet OR capsule OR oral
- Status Open to volunteers
Glaucoma
Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP)
Background Glaucoma is a multifactorial, chronic, and progressive eye disease characterized by the irreversible loss of retinal ganglion cells (RGCs).
- Trial name
- NCT07006194
- Testing
- Nicotinamide Tablet
- Where
- 3 sites in Italy
- Volunteers
- 360 people, healthy volunteers welcome
- Sponsor
- Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Glaucoma
Nicotinamide Supplementation in Glaucoma
The goal of this clinical trial is to learn if nicotinamide (NAM, vitamin B3) supplementation can delay glaucoma progression 30% above that achieved with conventional glaucoma treatment using topical medication.
- Trial name
- TAMING (NCT06731582)
- Testing
- Nicotinamide Tablet
- Where
- 2 sites in Singapore
- Volunteers
- 520 people
- Sponsor
- Singapore Eye Research Institute
Glaucoma
The Glaucoma Nicotinamide Trial
The Glaucoma Nicotinamide Trial (TGNT) is a prospective, randomized, placebo-controlled double-masked clinical trial composed of two cohorts; The Swedish Glaucoma Nicotinamide Trial (SGNT) and the Vitamin B3 In Glaucoma Study…
- Trial name
- TGNT (NCT05275738)
- Testing
- Nicotinamide
- Where
- 2 sites in Sweden
- Volunteers
- 660 people, healthy volunteers welcome
- Sponsor
- Umeå University
Glaucoma, Eye Disorders
Effectiveness of a Large Language Model-Based Educational Tool on Visual Field Test Reliability in Glaucoma Patients
The purpose of this study is to evaluate whether a large language model (LLM)-based audiovisual educational tool improves the test time and reliability of standard automated perimetry (SAP) using the SITA Standard 24-2 protocol…
- Conditions
- Glaucoma, Eye Disorders, Visual Fields, Visual Field Tests
- Trial name
- NCT07327242
- Testing
- LLM-based Education
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- Stanford University
Glaucoma, Primary Open Angle Glaucoma (POAG)
Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma
This study aims to evaluate the effects of BrudyGlauco, a nutritional supplement containing DHA (docosahexaenoic acid) and citicoline, on visual function in people with glaucoma.
- Conditions
- Glaucoma, Primary Open Angle Glaucoma (POAG), Neuroprotection
- Trial name
- BRUDYGLAUCO (NCT07322965)
- Testing
- BrudyGlauco
- Where
- 2 sites in Spain
- Volunteers
- 108 people
- Sponsor
- Institut Catala de Retina
Glaucoma
Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device
Glaucoma is a common and irreversible disease of the optic nerve. It is the second leading cause of blindness worldwide. Glaucoma can be treated with medication, laser therapy, or surgery; the latter is often necessary.
- Trial name
- PFLO (NCT07531199)
- Testing
- Classical surgery, Intraluminal suture
- Where
- France
- Volunteers
- 192 people
- Sponsor
- Hôpital Privé de la Baie
Primary Open-Angle Glaucoma (POAG), Cataract
Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract
This observational study will compare proteomic and elemental profiles of aqueous humor and ocular tissues in patients with primary open-angle glaucoma (POAG) and cataract versus cataract controls without glaucoma.
- Trial name
- NCT07462000
- Testing
- Phacoemulsification With Intraocular Lens Implantation and Deep Sclerectomy, Phacoemulsification With Intraocular Lens Implantation
- Where
- 2 sites in Poland
- Volunteers
- 40 people
- Sponsor
- Military Institute od Medicine National Research Institute
Primary Open Angle Glaucoma (POAG), Open-Angle Glaucoma
A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma
The aim of this clinical trial is to investigate whether oral semaglutide can be used to treat open-angle glaucoma. The main question it aims to answer is: Does oral semaglutide safely improve inner retinal function in patients…
- Conditions
- Primary Open Angle Glaucoma (POAG), Open-Angle Glaucoma, Glaucoma
- Trial name
- ABSALON (NCT06792422)
- Testing
- Oral semaglutide
- Where
- Denmark
- Volunteers
- 126 people
- Sponsor
- Glostrup University Hospital, Copenhagen
Glaucoma, Open-angle, Primary Open Angle Glaucoma (POAG)
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)
The goal of this clinical trial is to learn whether a high-dose vitamin B3 supplement called nicotinamide can protect retinal nerve cells in adults with primary open-angle glaucoma (POAG) who are already receiving standard…
- Trial name
- NADIR (NCT07808333)
- Testing
- Nicotinamide, Standard Glaucoma Therapy
- Where
- United States
- Volunteers
- 96 people
- Sponsor
- University of Chicago
Intraocular Pressure (IOP), Healthy Adult
Eplerenone and IOP in Healthy Adults
The goal of this clinical trial is to determine whether eplerenone lowers eye pressure in healthy adults. Eplerenone is a medication approved by the U.S. Food and Drug Administration for other medical conditions.
- Trial name
- NCT07795762
- Testing
- Eplerenone
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- University of Florida
Glaucoma
Modified Trabeculectomy After Failure of Combined Phaco With GATT
These procedures include deep non-penetrating sclerectomy, viscocanalostomy, and small incision trabeculectomy, avoiding Tenon's capsule.
- Trial name
- NCT07455786
- Testing
- Modified trabeculectomy
- Where
- Egypt
- Volunteers
- 20 people
- Sponsor
- Assiut University
Glaucoma
Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
The goal of this clinical trial is to determine whether oral supplementation with different nicotinamide adenine dinucleotide (NAD) precursors can improve visual function in adults with primary open-angle glaucoma.
- Trial name
- NCT06991712
- Testing
- Nicotinamide Riboside, Nicotinamide, Nicotinamide Mononucleotide
- Where
- Hong Kong
- Volunteers
- 138 people
- Sponsor
- Christopher Kai Shun Leung
Glaucoma, Open-Angle
Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
Glaucoma is the leading cause of sight impairment and blindness worldwide. It is a long-term eye disease which can cause permanent loss of sight and sometimes blindness and affects 1 in 50 people over 50 years of age.
- Trial name
- NAMinG (NCT05405868)
- Testing
- Nicotinomide
- Where
- 10 sites in United Kingdom
- Volunteers
- 496 people
- Sponsor
- University College, London
Open-angle Glaucoma, Pseudoexfoliation Glaucoma
Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients
This study aims to determine whether a combination of vitamins (B6, B9, B12, and choline) can help protect the eyes of people with glaucoma and slow vision loss.
- Trial name
- IVMGS (NCT06885827)
- Testing
- Vitamin B-mix, Standard Care
- Where
- 2 sites in Sweden
- Volunteers
- 80 people
- Sponsor
- Karolinska Institutet
Glaucoma
Metformin as a Neuroprotective Therapy for Glaucoma
Glaucoma, a chronic degenerative disease of the optic nerve, is the leading cause of irreversible blindness worldwide. Although lowering the intraocular pressure (IOP) has been shown to be effective to slow optic nerve…
- Trial name
- NCT05426044
- Testing
- Metformin
- Where
- Hong Kong
- Volunteers
- 125 people
- Sponsor
- Christopher Kai Shun Leung